ANI Pharmaceuticals, Inc. (ANIP) Dividend History
Income profile from 1998 to 2025 with payout safety and yield-on-cost trend
ANIP Dividend Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
ANIP Dividend Scorecard
Yield & Income
Payout Safety
Growth
Total Returns
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). ANIP's recent 5Y regime has been stronger than its full 10Y period, so 5Y can appear higher than 10Y.
ANIP Dividend History
No dividend payment history available
Get ANIP's next ex-dividend date and payout in your inbox
Monthly dividend calendar — upcoming ex-dates for stocks you follow.
Dividend Analysis
Payout Safety
ANI Pharmaceuticals, Inc. has limited earnings payout data (Unknown). When measured against free cash flow—a stricter test—the payout ratio stands at 0.7%, rated "Well Covered".
Piotroski F-Score: 6/9 — moderate financial health.
Growth Track Record
ANIP does not have a current streak of consecutive dividend increases, with a 3-year CAGR of -18.3%.
Total Shareholder Returns
Beyond cash dividends, ANIP returns capital through share repurchases. The combined picture: 0.1% dividend yield, 0.7% buyback yield, 0.7% total shareholder yield.
Income Trend & Total Return
The 5-year total return is 141.1%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $14,973 today.
ANIP Dividend vs Peers
Comparable companies in the same industry
ANIP Annual Dividend History (1998–2025)
28 years of dividend data
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | — | 0 | $3.32 | — | — | — |
| 2024 | $0.00 | — | 0 | $-1.04 | — | — | — |
| 2023 | $0.00 | — | 0 | $0.94 | — | — | — |
| 2022 | $0.00 | — | 0 | $-3.05 | — | — | — |
| 2021 | $0.00 | — | 0 | $-3.40 | — | — | — |
| 2020 | $0.00 | — | 0 | $-1.88 | — | — | — |
| 2019 | $0.00 | — | 0 | $0.50 | — | — | — |
| 2018 | $0.00 | — | 0 | $1.32 | — | — | — |
| 2017 | $0.00 | — | 0 | $-0.09 | — | — | — |
| 2016 | $0.00 | — | 0 | $0.34 | — | — | — |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
28+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ANIP — Frequently Asked Questions
Quick answers to the most common questions about buying ANIP stock.
How much dividend does ANIP pay per share?
ANI Pharmaceuticals, Inc. (ANIP) pays a trailing 12-month dividend of $0.05 per share, with a current dividend yield of +0.1%. Payments are made quarterly.
When is ANIP's next ex-dividend date?
ANIP's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. ANIP typically pays dividends quarterly.
Is ANIP's dividend safe?
ANIP's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of +0.7%. The dividend history does not yet show a prolonged growth streak.
How many years has ANIP increased its dividend?
ANIP has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does ANIP pay dividends?
ANI Pharmaceuticals, Inc. pays dividends quarterly. The trailing 12-month total is $0.05 per share. Dividend data on this page covers 27+ years from 1998 to 2025.
How much would $10,000 invested in ANIP grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in ANIP five years ago would be worth approximately $24,110 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is ANIP's yield on cost for long-term holders?
ANIP's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's +0.1% market yield, thanks to the lower original cost basis.